Analysts Set Teleflex Incorporated (NYSE:TFX) Target Price at $252.50

Teleflex Incorporated (NYSE:TFX) has earned an average rating of “Moderate Buy” from the seven research firms that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $252.50.

A number of equities research analysts have weighed in on the stock. Royal Bank of Canada cut their price target on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Mizuho decreased their price target on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, November 1st. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Finally, Truist Financial decreased their target price on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th.

Institutional Investors Weigh In On Teleflex

Institutional investors have recently bought and sold shares of the business. Simplify Asset Management Inc. acquired a new stake in shares of Teleflex during the third quarter worth approximately $4,800,000. JPMorgan Chase & Co. lifted its position in Teleflex by 14.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock worth $38,374,000 after buying an additional 19,466 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Teleflex by 4.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 398,175 shares of the medical technology company’s stock valued at $83,741,000 after buying an additional 15,992 shares during the period. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Teleflex by 19.8% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 484 shares of the medical technology company’s stock valued at $102,000 after acquiring an additional 80 shares in the last quarter. Finally, LGT Capital Partners LTD. increased its stake in shares of Teleflex by 4.2% in the third quarter. LGT Capital Partners LTD. now owns 231,685 shares of the medical technology company’s stock worth $57,300,000 after acquiring an additional 9,411 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Stock Performance

Shares of TFX opened at $180.63 on Friday. Teleflex has a 52-week low of $171.69 and a 52-week high of $256.85. The firm has a market capitalization of $8.39 billion, a PE ratio of 35.91, a P/E/G ratio of 1.72 and a beta of 1.16. The firm has a 50-day moving average price of $183.28 and a 200 day moving average price of $214.82. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, topping the consensus estimate of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $764.40 million for the quarter, compared to analysts’ expectations of $768.68 million. During the same quarter in the previous year, the company earned $3.64 earnings per share. The firm’s quarterly revenue was up 2.4% compared to the same quarter last year. On average, sell-side analysts anticipate that Teleflex will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, December 16th. Stockholders of record on Friday, November 15th were issued a dividend of $0.34 per share. The ex-dividend date was Friday, November 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.75%. Teleflex’s dividend payout ratio is 27.04%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.